Thursday, March 24, 2016

Aduro Biotech Announces First Patient Dosed in Combination Clinical Trial of CRS-207 and Epacadostat to Treat Ovarian Cancer

… platinum-resistant ovarian, fallopian or peritoneal cancers. For more information about the … express the tumor-associated antigen mesothelin, which is over-expressed in many cancers including … indications, including pancreatic, lung and prostate cancers, mesothelioma and glioblastoma. Aduro…

No comments:

Post a Comment